Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

NILUTAMIDE

NILUTAMIDE

Standard Dose
150MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview NILUTAMIDE is listed in Drugs@FDA under application 207631 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient NILUTAMIDE Form and strength TABLET;ORAL - 150MG Sponsor ANI PHARMS Submission history Latest submission status date: 2020-09-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview NILUTAMIDE is listed in Drugs@FDA under application 207631 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NILUTAMIDE Form and strength TABLET;ORAL - 150MG Sponsor ANI PHARMS Submission history Latest submission status date: 2020-09-04 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.